These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15529592)

  • 41. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-antiarrhythmic drugs for the prevention of cardiac arrhythmias.
    Di Biase M; Troccoli R; Brunetti ND
    Ital Heart J; 2005 Mar; 6(3):175-9. PubMed ID: 15875506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors: where do we stand now?
    Böhm M
    Am J Cardiol; 2007 Aug; 100(3A):38J-44J. PubMed ID: 17666197
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension due to primary aldosteronism: a case for exclusion.
    Bubbar CD; Blackburn DF; Wilson MP; Wilson TW
    Ann Pharmacother; 2007 Jan; 41(1):129-32. PubMed ID: 17179189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Aldosterone--classic and non classic effects].
    Karram T; Hoffman A; Abbasi A; Abassi Z
    Harefuah; 2002 Jun; 141(6):544-51, 578, 577. PubMed ID: 12119772
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A quick glance at rapid aldosterone action.
    Lösel R; Schultz A; Wehling M
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):137-41. PubMed ID: 15134812
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aldosterone and cardiovascular disease.
    Carey RM
    Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):194-8. PubMed ID: 20422779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toward a broader understanding of aldosterone in congestive heart failure.
    Weber KT; Sun Y; Wodi LA; Munir A; Jahangir E; Ahokas RA; Gerling IC; Postlethwaite AE; Warrington KJ
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):155-63. PubMed ID: 14608519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aldosterone--a hormone of cardiovascular adaptation and maladaptation.
    Goodfriend TL
    J Clin Hypertens (Greenwich); 2006 Feb; 8(2):133-9. PubMed ID: 16470083
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A symposium: International update--the important role of aldosterone and aldosterone antagonism in cardiovascular medicine. Based on symposia held in Brussels, Belgium and Newport Beach, California.
    Am J Cardiol; 1990 Jun; 65(23):1K-57K. PubMed ID: 2353664
    [No Abstract]   [Full Text] [Related]  

  • 51. Mechanisms of mineralocorticoid selectivity.
    Farman N
    Adv Nephrol Necker Hosp; 1999; 29():115-26. PubMed ID: 10561740
    [No Abstract]   [Full Text] [Related]  

  • 52. How can aldosterone act as a mineralocorticoid?
    Funder JW
    Endocr Res; 1989; 15(1-2):227-38. PubMed ID: 2759049
    [No Abstract]   [Full Text] [Related]  

  • 53. Hormone-nuclear receptor interactions in health and disease. Mineralocorticoid resistance.
    Komesaroff PA; Funder JW; Fuller PJ
    Baillieres Clin Endocrinol Metab; 1994 Apr; 8(2):333-55. PubMed ID: 8092976
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proceedings of the symposium Mineralocorticoids in Essential and Secondary Hypertension. Newport Beach, California, February 28, 1982.
    Clin Exp Hypertens A; 1982; 4(9-10):1447-934. PubMed ID: 7139969
    [No Abstract]   [Full Text] [Related]  

  • 55. Mechanisms of action of mineralocorticoid hormones.
    Rossier BC
    Endocr Res; 1989; 15(1-2):203-26. PubMed ID: 2667967
    [No Abstract]   [Full Text] [Related]  

  • 56. [Steroid hormone].
    Miyamori I; Hatakeyama H; Inaba S
    Nihon Rinsho; 2000 Jan; 58 Suppl 1():487-91. PubMed ID: 11026317
    [No Abstract]   [Full Text] [Related]  

  • 57. The role of aldosterone in the spectrum of cardiovascular and kidney disease risk: introduction.
    Bakris GL
    Semin Nephrol; 2014 May; 34(3):245-6. PubMed ID: 25016396
    [No Abstract]   [Full Text] [Related]  

  • 58. Aldosterone--an independent risk factor in cardiovascular disease.
    Melby JC
    J Clin Endocrinol Metab; 2002 Feb; 87(2):447. PubMed ID: 11836265
    [No Abstract]   [Full Text] [Related]  

  • 59. Microvascular effects of aldosterone and angiotensin type 2 receptors.
    Pallone TL
    Hypertension; 2005 May; 45(5):845-6. PubMed ID: 15781668
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effect of humoral factors on renal function in exsiccosis. III. Increased aldosterone activity in exsiccosis].
    GOMORI P; GLAZ E; WEISZ I; SUHANYECZYKY A; DESI I; RIGO J
    Magy Tud; 1958; 9(1):65-6. PubMed ID: 13599669
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.